Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors

Three patients with cholinesterase inhibitor poisoning have been presented. The patients were in a deep coma and, in one of them, artificial mechanical respiration was instituted. All three cases were treated by a procedure combining hemodialysis and hemoperfusion with Amberlite resin (XAD-4), and t...

Descripción completa

Detalles Bibliográficos
Autor principal: Durakovic, Zijad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 1993
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532091/
https://www.ncbi.nlm.nih.gov/pubmed/8031730
http://dx.doi.org/10.3904/kjim.1993.8.2.99
_version_ 1782385175553900544
author Durakovic, Zijad
author_facet Durakovic, Zijad
author_sort Durakovic, Zijad
collection PubMed
description Three patients with cholinesterase inhibitor poisoning have been presented. The patients were in a deep coma and, in one of them, artificial mechanical respiration was instituted. All three cases were treated by a procedure combining hemodialysis and hemoperfusion with Amberlite resin (XAD-4), and the clinical picture improved over a short period of time. After the end of procedure, the platelet count was approximately 41% of normal, some aspects of these intoxications are discussed.
format Online
Article
Text
id pubmed-4532091
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-45320912015-10-02 Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors Durakovic, Zijad Korean J Intern Med Original Article Three patients with cholinesterase inhibitor poisoning have been presented. The patients were in a deep coma and, in one of them, artificial mechanical respiration was instituted. All three cases were treated by a procedure combining hemodialysis and hemoperfusion with Amberlite resin (XAD-4), and the clinical picture improved over a short period of time. After the end of procedure, the platelet count was approximately 41% of normal, some aspects of these intoxications are discussed. Korean Association of Internal Medicine 1993-07 /pmc/articles/PMC4532091/ /pubmed/8031730 http://dx.doi.org/10.3904/kjim.1993.8.2.99 Text en Copyright © 1993 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Durakovic, Zijad
Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
title Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
title_full Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
title_fullStr Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
title_full_unstemmed Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
title_short Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
title_sort combined hemoperfusion and hemodialysis treatment of poisoning with cholinesterase inhibitors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532091/
https://www.ncbi.nlm.nih.gov/pubmed/8031730
http://dx.doi.org/10.3904/kjim.1993.8.2.99
work_keys_str_mv AT durakoviczijad combinedhemoperfusionandhemodialysistreatmentofpoisoningwithcholinesteraseinhibitors

Ejemplares similares